Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Dec 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying children and teenagers who have recently been diagnosed with Type 1 Diabetes (T1D). The goal is to identify certain factors that might help doctors understand how well a patient’s body responds to insulin right after their diagnosis. By knowing these factors, doctors can provide the right amount of insulin more quickly, which can help manage the condition better and potentially reduce the time patients need to spend in the hospital.

To be eligible for this study, participants must be 14 years old or younger and have been diagnosed with Type 1 Diabetes between January 2014 and December 2018 at a specific hospital in Bologna, Italy. Additionally, they need to have had at least one year of follow-up care after their diagnosis. Throughout the study, parents or guardians will need to give their consent for their child to participate. This trial is currently recruiting participants, and it aims to help improve the overall care and treatment for young people with Type 1 Diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≤ 14 years at the time of diagnosis of type 1 diabetes;
• • Diagnosis of type 1 diabetes confirmed between January 2014 and December 2018 at the Pediatrics Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy;
• • Patients with at least 1 year of follow-up after diagnosis od type 1 diabetes;
• • Obtaining informed consent from parents/legal guardian of pediatric patients.
• Exclusion Criteria:
• • Patients with diabetes other that type 1;
• • Patients followed at other centres at the time of onset of type 1 diabetes.